Benjamin Edwards’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Benjamin Edwards's BIO Position: Q3 2026 in Review
Benjamin Edwards increased its Bio-Rad Laboratories Class A (BIO) stake by 8.8% in Q3 2026, buying an estimated $50.6K and bringing the position to 1,788 shares worth $675K. The position accounts for 0.01% of the portfolio, ranked #951.
Benjamin Edwards first reported a position in BIO in Q3 2021 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Benjamin Edwards held 1,788 shares of Bio-Rad Laboratories Class A worth $675K as of Q3 2026.
- Benjamin Edwards bought 145 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $50.6K.
- Bio-Rad Laboratories Class A made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #951 holding.
- Benjamin Edwards first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and has held it in 7 quarters since.
- 327 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.